SRN001
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
siRNAgen Therapeutics Inc.
Overview
SRN001 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
SRN001 clinical trials
Explore related
Medical disclaimer. This page summarizes research about SRN001 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.